PTGS2 and epilepsy: Clinical data indicate the COX-2 upregulation in hippocampal biopsies from patients with therapy-refractive temporal lobe epilepsy [49], which is consistent with the previous findings of increased concentrations of PGF2α in the CSF of epilepsy patients [46,50].